2012
HLA-G and HLA-E specific mRNAs connote opposite prognostic significance in renal cell carcinoma
KŘEN, Leoš; Ivo VALKOVSKÝ; Jan DOLEŽEL; Ivo ČAPÁK; Dalibor PACÍK et al.Základní údaje
Originální název
HLA-G and HLA-E specific mRNAs connote opposite prognostic significance in renal cell carcinoma
Autoři
KŘEN, Leoš; Ivo VALKOVSKÝ; Jan DOLEŽEL; Ivo ČAPÁK; Dalibor PACÍK; Alexandr POPRACH; Radek LAKOMÝ; Martina RÉDOVÁ; Pavel FABIAN; Zdenka KŘENOVÁ a Ondřej SLABÝ
Vydání
Diagnostic Pathology, LONDON, BIOMED CENTRAL LTD, 2012, 1746-1596
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30200 3.2 Clinical medicine
Stát vydavatele
Velká Británie a Severní Irsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 1.850
Označené pro přenos do RIV
Ano
Kód RIV
RIV/00216224:14110/12:00060120
Organizační jednotka
Lékařská fakulta
UT WoS
Klíčová slova anglicky
renal cell carcinoma; radiotherapy; chemotherapy; HLA-G; HLA-E
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 22. 4. 2013 18:23, Soňa Böhmová
Anotace
V originále
Background: Renal cell carcinoma (RCC) is characterized by its resistance to radiotherapy and/or chemotherapy. On the other hand, it is an immunogenic tumor - it is able to stimulate antitumor responses. A prognostic significance of HLA-G expression by neoplastic cells in RCC is not well characterized; significance HLA-E expression in RCC is not characterized at all. Methods: In our study, we evaluated the expression of HLA-G and HLA-E specific mRNA transcripts produced by neoplastic cells in 38 cases of RCC and in 10 samples of normal kidney parenchyma. The results were statistically correlated with various clinico-pathological parameters. Results: We confirmed that HLA-G is downregulated in normal kidney tissue; if it is up-regulated in RCC, then it is connected to worse prognosis. On the other hand, HLA-E mRNA transcripts were present in both normal kidney tissue and RCC and their increasing concentrations counterintuitively carried better prognosis, more favorable pT stage and lower nuclear Fuhrmann's grade. Conclusion: Considering the fact that there is known aberrant activation of HLA-G and HLA-E expression by interferons, identification of HLA-G and HLA-E status could contribute to better selection of RCC patients who could possibly benefit from more tailored neoadjuvant biological/immunological therapy. Thus, these molecules could represent useful prognostic biomarkers in RCC, and the expression of both these molecules in RCC deserves further study. The virtual: Slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/7383071387016614
Návaznosti
| ED1.1.00/02.0068, projekt VaV |
|